Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar combined with CHOPT for T-cell lymphoma
ChiCTR-ONRC-11001598Phase 4Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of endostar in T-cell lymphoma, sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoints: VEGF levels in tissue, serum, and bone marrow, Tumor response and 4 more. Started Sep 2014; status: completed.
02
Drugs
endostar
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on ChiCTR-ONRC-11001598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-11001598.